Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHCY | P23526 | 16/20 | 0.73 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.64 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.64 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.64 |
| ▸ | P2RY1 | P47900 | 2/20 | 0.61 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.61 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.61 |
| ▸ | TRPM2 | O94759 | 1/20 | 0.61 |
| ▸ | LDHA | P00338 | 1/20 | 0.61 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.61 |
| ▸ | FBP1 | P09467 | 1/20 | 0.61 |
| ▸ | SRC | P12931 | 1/20 | 0.61 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.61 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.61 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.61 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.61 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.61 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.61 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 0.61 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3313635 | 1.00 | AHCY (0.73) | AHCYHIF1ATMEM97SIGMAR1P2RY1 | |
| SCHEMBL3313598 | 1.00 | AHCY (0.73) | AHCYHIF1ATMEM97SIGMAR1P2RY1 | |
| SCHEMBL4744376 | 1.00 | AHCY (0.73) | AHCYHIF1ATMEM97SIGMAR1P2RY1 | |
| SCHEMBL3315660 | 0.92 | AHCY (0.64) | AHCYHIF1ATMEM97SIGMAR1P2RY1 | |
| SCHEMBL14102397 | 0.92 | AHCY (0.64) | AHCYHIF1ATMEM97SIGMAR1P2RY1 | |
| SCHEMBL3317481 | 0.92 | AHCY (0.64) | AHCYHIF1ATMEM97SIGMAR1P2RY1 | |
| SCHEMBL14102406 | 0.92 | AHCY (0.64) | AHCYHIF1ATMEM97SIGMAR1P2RY1 | |
| SCHEMBL3317471 | 0.92 | AHCY (0.64) | AHCYHIF1ATMEM97SIGMAR1P2RY1 | |
| SCHEMBL13396706 | 0.92 | AHCY (0.64) | AHCYHIF1ATMEM97SIGMAR1P2RY1 | |
| SCHEMBL3315677 | 0.92 | AHCY (0.64) | AHCYHIF1ATMEM97SIGMAR1P2RY1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8324179-B2 | Nucleoside analogs for antiviral treatment | GILEAD SCIENCES, INC. (US) | 2012-12-04 | — | — | US | disclosed |
| US-20100104532-A1 | NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT | GILEAD SCIENCES, INC. (US) | 2010-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100104532-A1 | NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT | SLC29A1, NUDT1, EIF2AK2 | AHCY 2428/4885HIF1A 3736/4885TMEM97 3096/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.